登录新浪财经APP 搜索【信披】查看更多考评等级 关于回购股份事项前十名股东 和前十名无限售条件股东持股情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 恒通物流股份有限公司（以下简称"公司"）于2026年1月20日召开第五届董事会第十五次会议审议通过 了《关于以集中竞价交易方式回购公司股份方案的议案》，拟使用不低于人民币8,000万元（含），不 超过人民币10,000万元（含）的自有资金，通过集中竞价交易方式回购公司股份，用于减少公司注册资 本，该回购方案尚需提交公司2026年第一次临时股东会审议，具体回购方案详见公司于2026年1月21日 在上海证券交易所网站（www.sse.com.cn）披露的《恒通物流股份有限公司关于以集中竞价交易方式回 购股份方案的公告》（公告编号：2026-004）。 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第7号一一回购股份》等相关 规定，现将回购股份董事会会议决议公告前一个交易日（即2026年1月20日）登记在册的前十名股东和 前十名无限售条件股东的名称 ...

Group 1 - The controlling shareholder of Hengtong Logistics, Nanshan Group, holds approximately 295 million shares, accounting for 41.3% of the company's total equity [1] - After the release of the pledge, Nanshan Group has cumulatively pledged about 161 million shares, which represents 54.59% of its holdings in the company [1]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 股票代码：603223 股票简称：恒通股份 公告编号：2026-008 恒通物流股份有限公司 关于控股股东部分股份解除质押的公告 一、 本次股份解除质押情况 公司近日接到控股股东南山集团关于其解除部分股份质押登记的通知，现将 有关情况公告如下： | 股东名称 | 南山集团 | | --- | --- | | 本次解质股份 | 54,833,441股 | | 占其所持股份比例 | 18.59% | | 占公司总股本比例 | 7.68% | | 解除质押时间 | 2026年1月20日 | | 持股数量 | 294,944,408股 | | 持股比例 | 41.30% | | 剩余被质押股份数量 | 160,996,645股 | | 剩余被质押股份数量占其所持股份比例 | 54.59% | | 剩余被质押股份数量占公司总股本比例 | 22.54% | 本次股份解除质押后，南山集团若存在后续质押计划，其将根据实际质押情 况及时履行告知义务，公司将及时履行信息披露义务。 截 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 恒通物流股份有限公司（以下简称"公司"）于2026年1月20日召开第五届 董事会第十五次会议审议通过了《关于以集中竞价交易方式回购公司股份方案的 议案》，拟使用不低于人民币8,000万元（含），不超过人民币10,000万元（含） 的自有资金，通过集中竞价交易方式回购公司股份，用于减少公司注册资本，该 回购方案尚需提交公司2026年第一次临时股东会审议，具体回购方案详见公司于 2026年1月21日在上海证券交易所网站（www.sse.com.cn）披露的《恒通物流股 份有限公司关于以集中竞价交易方式回购股份方案的公告》（公告编号： 2026-004）。 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7号——回购股份》等相关规定，现将回购股份董事会会议决议公告前一个交易 日（即2026年1月20日）登记在册的前十名股东和前十名无限售条件股东的名称、 持股数量及持股比例公告如下： 股票代码：603223 股票简称：恒通股份 公告编号：2026-007 恒通物 ...

经济观察网2026年1月20日，恒通股份（603223）发布公告，公司拟8000万元至1亿元回购股份，回购价 格不超过14.5元/股。 ...

Group 1: Delisting Risks - *ST Xin Yan: The Shenzhen Stock Exchange has approved the company's application to revoke the delisting risk warning due to restructuring [1] - *ST Zhong Zhuang (Rights Protection): The delisting risk warning has been revoked, but other risk warnings will continue, and the stock will be suspended for one day starting tomorrow [2] - ST Sai Wei: Expected to incur a loss of 720 million to 1.02 billion yuan in 2025, with a possibility of being subject to delisting risk warnings [3] Group 2: Earnings Forecasts - Hikvision: Expected net profit attributable to shareholders to grow by 18.46% year-on-year in 2025 [28] - Langzi Co.: Expected net profit to increase by 245.25% to 302.8% year-on-year in 2025 [4][30] - Zhaoyan New Drug: Expected net profit to increase by 214% to 371% year-on-year in 2025 [5][30] - Huachen Equipment: Expected net profit to increase by 193.64% to 242.04% year-on-year in 2025 [6][30] - Qianyuan Power: Expected net profit to increase by 160% to 190% year-on-year in 2025 [7][30] - Jin Fang Energy: Expected net profit to increase by 123.97% to 193.7% year-on-year in 2025 [8][31] - Zhongfu Industrial: Expected net profit to increase by 120.27% to 141.59% year-on-year in 2025 [9][32] - Batian Co.: Expected net profit to increase by 117.53% to 139.53% year-on-year in 2025 [10][32] - Zhongrong Electric: Expected net profit to increase by 104.89% to 131.10% year-on-year in 2025 [11][32] - Kaisheng New Materials: Expected net profit to increase by 96.47% to 150.06% year-on-year in 2025 [12][32] - Putailai: Expected net profit to increase by 93.18% to 101.58% year-on-year in 2025 [13][32] - Dongfang Iron Tower: Expected net profit to increase by 91.4% to 125.07% year-on-year in 2025 [14][32] - Pulaike: Expected net profit to increase by 89.64% to 110.11% year-on-year in 2025 [15][32] - Huabang Health: Expected profit of 660 million to 730 million yuan in 2025, turning from loss to profit [16][32] - Hongyuan Green Energy: Expected net profit of 180 million to 250 million yuan in 2025, turning from loss to profit [17][32] - Kangda New Materials: Expected profit of 125 million to 135 million yuan in 2025, turning from loss to profit [18][32] - Langxin Technology: Expected profit of 100 million to 150 million yuan in 2025, turning from loss to profit [19][32] - Hualv Biological: Expected profit of 100 million to 130 million yuan in 2025, turning from loss to profit [20][32] Group 3: Mergers and Acquisitions - Kangxin New Materials: Plans to acquire 51% of Yubang Semiconductor for 392 million yuan [21][32] - Aibo Medical: Plans to gain control of Demei Medical [22][32] Group 4: Share Buybacks and Reductions - Hengtong Co.: Plans to repurchase company shares worth 80 million to 100 million yuan [24][32] - Haier Smart Home: Plans to repurchase D shares up to 200,000 euros [29][32] - Blue Universe Co.: Shareholders plan to reduce their holdings by no more than 3.02% [29][32] - Hesheng Silicon Industry: Controlling shareholder plans to reduce holdings by no more than 3% [29][32] - Aolian Electronics (Rights Protection): Shareholder Liu Junsheng plans to reduce holdings by no more than 3% [29][32] - Bluefeng Biochemical: Hainan Wenqin plans to reduce holdings by no more than 3% [29][32] - Zhixin Precision: Shareholders plan to reduce holdings by no more than 3% [29][32] - Peking University Medical: Peking University Health plans to reduce holdings by no more than 3% [29][32] Group 5: Other Updates - Liou Co.: Self-inspection work has been completed, and the stock will resume trading on January 21 [29][32] - Yongxing Materials: The lithium mica green intelligent and efficient lithium extraction project has reached production capacity [29][32] - Debang Co.: Plans to voluntarily withdraw A shares from trading on the Shanghai Stock Exchange [29][32]

Group 1 - The company plans to change the purpose of repurchased shares from "for employee stock ownership plan or equity incentives" to "reduce registered capital" [1][2] - The company has completed the repurchase of 8,364,853 shares, accounting for 1.17% of the total share capital, with a total transaction amount of approximately RMB 79.98 million [1][2] - The board of directors has proposed to the shareholders' meeting to authorize the management to handle the cancellation of the repurchased shares [5][6] Group 2 - The company expects to achieve a net profit attributable to shareholders of RMB 25 million to 28 million for the year 2025, an increase of 61.22% to 80.57% compared to the previous year [8][10] - The increase in profit is primarily due to the operational commencement of a production berth by a wholly-owned subsidiary, leading to significant growth in port business profits [11][12] - The forecasted net profit excluding non-recurring gains and losses is also expected to increase by 63.47% to 83.09% compared to the previous year [10][11] Group 3 - The company will hold a temporary shareholders' meeting on February 5, 2026, to discuss the proposed changes and repurchase plans [66][67] - The meeting will adopt a combination of on-site and online voting methods [66][67] - Shareholders must register for the meeting between February 3 and February 4, 2026 [70]

Group 1: Earnings Forecasts - Huabang Health expects a net profit of 660 million to 730 million yuan for 2025, recovering from a loss of 299 million yuan in the previous year, driven by improvements in its agricultural chemical materials sector and steady growth in its pharmaceutical and tourism segments [2] - Kangda New Materials anticipates a net profit of 125 million to 135 million yuan for 2025, compared to a loss of 246 million yuan last year, primarily due to significant sales growth in adhesive and specialty resin products, particularly in the wind power sector [2] - Longxin Technology forecasts a net profit of 100 million to 150 million yuan for 2025, recovering from a loss of 250 million yuan, with improvements in its energy digitalization business and reduced losses in its new energy sector [3] - Hualu Bio expects a net profit of 100 million to 130 million yuan for 2025, recovering from a loss of 47.57 million yuan, attributed to increases in both sales price and volume [3] - Jiuxi Software predicts a net profit of 40 million to 60 million yuan for 2025, recovering from a loss of 156 million yuan, supported by AI technology enhancements and market expansion strategies [3] Group 2: Major Corporate Developments - Liou Co. has completed its stock suspension review and will resume trading on January 21, 2026, confirming that its business operations remain normal and no significant undisclosed matters exist [4] - Hikvision reported total revenue of 92.518 billion yuan for 2025, a slight increase of 0.02%, with a net profit of 14.188 billion yuan, up 18.46%, driven by strategic adjustments and improved cash flow management [6] - JianTou Energy expects a net profit of approximately 1.877 billion yuan for 2025, a significant increase of about 253.38% from the previous year, due to optimized coal resource allocation and cost management [6] Group 3: Investment and Mergers - Aibo Medical plans to acquire at least 51% of Demai Medical to gain control, aiming to leverage its R&D advantages in the sports health sector [19] - Yifan Transmission intends to purchase 87.07% of Beijing Helishi Motor Technology Co., which will become a subsidiary upon successful completion of the transaction [16] - Guangdong Hongtu plans to invest up to 95 million yuan to establish a subsidiary in Thailand for automotive parts production and sales [20] Group 4: Stock Performance and Changes - Huicheng Environmental's major shareholder plans to increase their stake in the company by investing between 25 million and 50 million yuan within six months [22] - Liou Co. will resume trading after completing its stock suspension review, indicating stability in its operations [24] - Kailong High-Tech and Debang Co. have been suspended from trading, indicating potential issues or developments requiring further clarification [25]

Key Highlights - Daying Electronics reported current revenue from its unmanned robot business [1] - Hite Bio is planning to issue H-shares and list on the Hong Kong Stock Exchange [1] - Huangshan Tourism is investing approximately 133 million yuan in the upgrade of the Huangshan Tai Ping cableway electrical system [1] - Huatai Technology signed a daily operation contract worth 328 million yuan [1] - Tonghuashun expects a net profit growth of 50%-80% year-on-year for 2025 [1] - Kangxin New Materials plans to acquire 51% equity in Zibang Semiconductor for 392 million yuan [1] - Hengtong Co. intends to repurchase shares worth between 80 million to 100 million yuan [1] - Lanyu Co. shareholders Wang Yinghai and Yushuo Investment plan to reduce their holdings by up to 3% [1][2] - Jinma Amusement plans to raise no more than 1.05 billion yuan through a private placement [2] - Jincai Interconnection plans to raise no more than 570 million yuan through a private placement [2] Investment Projects - Kaizhong Precision plans to upgrade and expand its manufacturing base for new energy vehicle components in Heyuan [1] - Jiangtian Chemical intends to invest in a project with an annual production capacity of 60,000 tons of acrylic acid [1] - Nanjing Julong plans to establish a wholly-owned subsidiary to invest in a modified plastic production line project [1] Performance Forecasts - Batian Co. expects a net profit growth of 117.53% to 139.53% year-on-year for 2025 [1] - Tongfu Microelectronics anticipates a net profit of 1.1 billion to 1.35 billion yuan for 2025, representing a year-on-year growth of 62.34% to 99.24% [1] - Putailai expects a year-on-year increase in net profit of 93.18% to 101.58% for the 2025 fiscal year [1]

（编辑 王雪儿） 证券日报网讯 1月20日，恒通股份发布公告称，公司预计2025年年度实现归属于母公司所有者的净利润 25000万元到28000万元，与上年同期相比，将增加9493.18万元到12493.18万元，同比增加61.22%到 80.57%。 ...